The Jackson Laboratory — a biomedical research institution with locations in Bar Harbor, Maine, Sacramento, Calif., and Farmington, Conn. — will use the grant to construct a new Center for Systems Neurogenetics of Addiction.
J. David Jentsch, PhD, professor of psychology at Binghamton (N.Y.) University, is a part of the team of investigators whose research will be supported by the NIH grant. Dr. Jentsch and his team will use state-of-the-art mouse models to identify genes and genetic pathways linked addiction risks.
“Today, a key focus in treatment is to reverse or minimize the harm of an already established addiction,” said Dr. Jentsch. “Ideally, we would like to identify people that are at risk and prevent their development of an addiction before it leaves its indelible mark on them. This research program advances that mission, and through its collaborative synergy, it stands an excellent chance of success.”
More articles on population health:
Rates of pregnancy-related deaths nearly double in Texas
Why McDonald’s stopped giving out its newest Happy Meal toys
July 2016 was the hottest month ever
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.